Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women

2019120 citationsJournal Articlebronze Open Access

Authors

Amita Gupta · Johns Hopkins University

Grace Montepiedra · National Institutes of Health

Lisa Aaron · National Institutes of Health

Gerhard Theron · National Institutes of Health

Katie McCarthy · Family Health International 360

Sarah Bradford · Family Health International 360

Tsungai Chipato

Abstract

The risks associated with initiation of isoniazid preventive therapy during pregnancy appeared to be greater than those associated with initiation of therapy during the postpartum period. (Funded by the National Institutes of Health; IMPAACT P1078 TB APPRISE ClinicalTrials.gov number, NCT01494038.).

Topics & Keywords

Tuberculosis Research and Epidemiology Pneumocystis jirovecii pneumonia detection and treatment Diagnosis and treatment of tuberculosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 381, Issue 14, pp. 1333-1346

DOI: 10.1056/nejmoa1813060

Field-Weighted Citation Impact: 10.40